The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational studyHironori Fujii, Hirotoshi Iihara, Daichi Watanabe et al.|Supportive Care in Cancer|2024Cited by 1